Researchers developed a tool for predicting the prognosis of people with chronic lung disease-related pulmonary hypertension.

Thirteen-year-old Ty deals with pulmonary hypertension, a high blood pressure condition that affects the arteries in the ...

Tectonic Therapeutic. TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group ...

The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...

Liquidia Corporation has announced a significant financial move by amending its agreement with Healthcare Royalty to ...

Liquidia Co. (NASDAQ:LQDA – Get Free Report) gapped down prior to trading on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $14.74, but opened at $14.38 ...

Berhampur: Police registered criminal cases against seven hotel owners in the silk city for allegedly operating illegal ...

Merck's stock recently got a cardio boost, jumping 13% in a month thanks to some pulse-quickening developments. The company ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

The changes come as pharmacy benefit managers face scrutiny for how they require doctors and patients to seek its approval for certain treatments and drugs.

Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of United ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...